drugset / Trial / NCT07046364

Remimazolam and Emergence Delirium in Pediatrics

NCT07046364

Phase 4 Recruiting 248 enrolled Peking University First Hospital
RandomizedParallel-groupQuadruple-blindPrevention

Summary

Emergence delirium is a common complication in pediatrics undergoing neurosurgery. Previous study showed that a single bolus of remimazolam was associated with lower incidence of postoperative agitation. Present study was designed to investigate if remimazolam supplemented to sevoflurane anesthesia could decrease the risk of emergence delirium in pediatrics undergoing neurosurgery.

Timeline

Start
2025-01-01
Primary completion
2027-01-01
Completion
2027-01-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Remimazolam Small molecule 1 mg/kg Other

Indications